RENAISSANCE TECHNOLOGIES LLC

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1037389 NEW YORK, NY

Position in SNDX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,030,176

-$4,607,776 QoQ

Shares Held

321,600

-35.4% QoQ

Ownership

0.360%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#61

of 242 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. SNDX ranks #68 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,030,176	321,600	-35.4%	Shares	Sole	2026-08-13
2026-03-31	$11,637,952	498,200	-8.6%	Shares	Sole	2026-05-14
2025-12-31	$11,446,248	544,800	-36.7%	Shares	Sole	2026-02-12
2025-09-30	$13,238,792	860,500	+2.7%	Shares	Sole	2025-11-13
2025-06-30	$7,845,060	837,700	+22.9%	Shares	Sole	2025-08-13
2025-03-31	$8,371,330	681,427	+0.1%	Shares	Sole	2025-05-14
2024-12-31	$9,002,357	680,965	+217.8%	Shares	Sole	2025-02-13
2024-06-30	$4,399,579	214,300	+170.9%	Shares	Sole	2024-08-09
2024-03-31	$1,882,580	79,100	-63.8%	Shares	Sole	2024-05-13
2023-09-30	$3,169,716	218,300	+168.8%	Shares	Sole	2023-11-14
2022-12-31	$2,066,540	81,200	-55.4%	Shares	Sole	2023-02-13
2022-03-31	$3,164,898	182,100	+92.3%	Shares	Sole	2022-05-13
2020-06-30	$1,403,454	94,700	-80.6%	Shares	Sole	2020-08-13
2020-03-31	$5,348,972	487,600	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.